March 31, 2009 (Orlando, Florida) — New data from the HORIZONS AMI trial suggest that inadequate very early antithrombin and antiplatelet therapy is one of the strongest drivers of early stent ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

In 1988, Wheeler et al. [8] reported that physicians treating patients for pulmonary embolism and deep-vein thrombosis frequently underdosed their patients and were slow to change their heparin ...

SAN FRANCISCO, CALIF.—In a study of patients who received either bivalirudin or heparin for non-emergent, balloon aortic valvuloplasty, bivalirudin was associated with less bleeding, according to a ...

Limitations of commonly used anticoagulants, unfractionated heparin, low-molecular-weight heparin, and oral vitamin K antagonists have prompted the development of alternative therapies. Direct ...

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic syndrome in which one or more clinical events, usually thrombocytopenia or thrombosis, are temporally related to heparin administration ...

Please provide your email address to receive an email when new articles are posted on . Baxter Healthcare has temporarily stopped manufacturing multiple-dose vials of heparin due to reports of serious ...

The Food and Drug Administration (FDA) has disclosed that the number of cases reporting adverse reactions due to Heparin, a brand of blood thinner manufactured by Baxter International, is rising.

Anecdotal reports of subtherapeutic heparin have kept many cardiologists across the world on edge over the past couple of months, although no regulatory authority has yet confirmed a specific problem.

Please provide your email address to receive an email when new articles are posted on . Reports of serious allergic reactions, hypotension and even death have caused Baxter Healthcare Corporation to ...

CHICAGO (Reuters) - Baxter International Inc on Monday said it has temporarily stopped making the blood-thinner heparin in multi-dose vials after four patients who took the drug died and hundreds of ...